Indaptus Therapeutics Inc is trading at $3.52 (5.4% down) in after-hours sessions as investors lock in gains following a significant multi-day surge.
- The stock recently experienced a massive rally, including a 45.71% jump on June 11 and a 20.99% gain on June 10.
- Broader market sentiment turned risk-off, with the S&P 500 falling 0.58% and the Nasdaq Composite dropping 1.09%, adding pressure to the stock.
- No company-specific news or earnings releases were provided, suggesting the move is driven by extended-hours volatility and technical corrections.